| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a15dc21ae8f74d3004862e0184040f9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc927f580527f99fb796d9b365b54ed9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c298e7046bafcd41749492792f54444d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38a4acb110f97babd91867bfb3de3ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b994b02cc55ea5a9570547c20c93c2c1 |
| publicationDate |
2003-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2835838-A1 |
| titleOfInvention |
OLIGONUCLEOTIDES INHIBITORS AND THEIR USE FOR SPECIFICALLY REPRESSING A GENE ENCODING A TRANSCRIPTION FACTOR |
| abstract |
The subject of the invention is a double-stranded oligonucleotide intended for specifically suppressing a gene, said oligonucleotide consisting of two oligonucleotide sequences of the same size each comprising at the same 3 'or 5' end one to five unpaired nucleotides forming single-stranded ends overflowing from the hybrid, characterized in that one of said oligonucleotide sequences is substantially complementary to a target sequence belonging to a DNA or RNA molecule messenger of a gene for a desired transcription factor specifically suppress. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020500217-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008035291-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2314691-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008035291-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110114076-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3058062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8575329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018078303-A1 |
| priorityDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |